Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV methicillin-resistant Staphylococcus aureus (MRSA)

References

1. Asokan GV, Ramadhan T, Ahmed E, Sanad H. WHO global priority pathogens list: a bibliometric analysis of medline-PubMed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J 2019; 34:184–193 [View Article]
   [Google Scholar]
2. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46 Suppl 5:S350–9 [View Article]
   [Google Scholar]
3. Udo EE. Community-acquired methicillin-resistant Staphylococcus aureus: the new face of an old foe?. Med Princ Pract 2013; 22 Suppl 1:20–29 [View Article]
   [Google Scholar]
4. Shahzad S, Ashraf MA, Sajid M, Shahzad A, Rafique A et al. Evaluation of synergistic antimicrobial effect of vitamins (A, B1, B2, B6, B12, C, D, E and K) with antibiotics against resistant bacterial strains. J Glob Antimicrob Resist 2018; 13:231–236 [View Article]
   [Google Scholar]
5. Pandit S, Ravikumar V, Abdel-Haleem AM, Derouiche A, Mokkapati VRSS et al. Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms. Front Microbiol 2017; 8:2599 [View Article]
   [Google Scholar]
6. Tintino SR, Morais-Tintino CD, Campina FF, Pereira RL, Costa M do S et al. Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps. EXCLI J 2016; 15:315–322 [View Article]
   [Google Scholar]
7. Kawata A, Murakami Y, Suzuki S, Fujisawa S. Anti-inflammatory activity of β-Carotene, Lycopene and Tri-n-butylborane, a scavenger of reactive oxygen species. In Vivo 2018; 32:255–264 [View Article]
   [Google Scholar]
8. Boye K, Bartels MD, Andersen IS, Møller JA, Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect 2007; 13:725–727 [View Article]
   [Google Scholar]
9. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2004; 48 Suppl:
   [Google Scholar]
10. Garcia LS, Isenberg HD. Clinical Microbiology Procedures Handbook 2010 [View Article]
    [Google Scholar]
11. CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st. edn Wayne, PA: Clinical and Laboratory Standards Institute; 2021
    [Google Scholar]
12. Naidu KA. Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2003; 2:2–7 [View Article]
    [Google Scholar]
13. Amábile-Cuevas CF, Heinemann JA. Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tactic. Drug Discov Today 2004; 9:465–467 [View Article]
    [Google Scholar]
14. Vilchèze C, Hartman T, Weinrick B, Jacobs WR. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun 2013; 4:1881 [View Article]
    [Google Scholar]
15. Murray MF. Nicotinamide: An Oral Antimicrobial Agent With Activity Against Both Mycobacterium tuberculosis and Human Immunodeficiency Virus Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; 2003 pp 453–460
    [Google Scholar]
16. Rolfe HM. A review of nicotinamide: treatment of skin diseases and potential side effects. J Cosmet Dermatol 2014; 13:324–328 [View Article]
    [Google Scholar]
17. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 31st edn. edn Wayne, Pennsylvania 19087 USA: Clinical and Laboratory Standards Institute; 2021
    [Google Scholar]
18. Khameneh B, Fazly Bazzaz BS, Amani A, Rostami J, Vahdati-Mashhadian N. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog 2016; 93:83–87 [View Article]
    [Google Scholar]
19. Vilchèze C, Kim J, Jacobs WR. Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line Tuberculosis drugs isoniazid and Rifampin in mice. Antimicrob Agents Chemother 2018; 62:e02165-17 [View Article]
    [Google Scholar]
20. Cursino L, Chartone-Souza E, Nascimento AMA. Synergic interaction between ascorbic acid and antibiotics against Pseudomonas aeruginosa. Braz Arch Biol Technol 2005; 48:379–384 [View Article]
    [Google Scholar]
21. El-Saied N, Amer M, Elbohoty A, Saad M, Mansour M. Efficacy of vitamin C vaginal suppository in treatment of bacterial vaginosis a randomized controlled trial. J Gynecol Res 2016; 2: [View Article]
    [Google Scholar]
22. Mohammad-Alizadeh S, Dokhanchi T, Hakimi S, Javadzadeh Y, Takallu L et al. The addition of vitamin C vaginal tablets to oral metronidazole and its effect on the treatment and recurrence of bacterial vaginosis: a randomized triple-blind clinical trial. Int J Women’s Health Reprod Sci 2017; 5:193–199 [View Article]
    [Google Scholar]
23. Hesham El-Sherazy N, Samir Bazan N, Mahmoud Shaheen S, A Sabri N. Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: a preliminary randomized controlled trial. F1000Res 2021; 10:929 [View Article]
    [Google Scholar]
24. Takigawa M, Yatsu T, Takino Y, Matsumoto S, Kitano T et al. High-dose vitamin C preadministration reduces vancomycin-associated nephrotoxicity in mice. J Nutr Sci Vitaminol 2019; 65:399–404 [View Article]
    [Google Scholar]
25. Xu C, Dong N, Chen K, Yang X, Zeng P et al. Bactericidal, anti-biofilm, and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent Klebsiella pneumoniae. iScience 2022; 25:103894 [View Article]
    [Google Scholar]
26. Shivaprasad DP, Taneja NK, Lakra A, Sachdev D. In vitro and in situ abrogation of biofilm formation in E. coli by vitamin C through ROS generation, disruption of quorum sensing and exopolysaccharide production. Food Chem 2021; 341:128171 [View Article]
    [Google Scholar]